Modern approaches in the problem of epilepsy in the practice of a nurse
- Авторлар: Gulian S.G.1, Tsetsera D.E.1, Skvortsov V.V.1, Rodionova I.V.1
-
Мекемелер:
- Volgograd State Medical University of the Ministry of Health of the Russian Federation
- Шығарылым: Том 26, № 6 (2024)
- Беттер: 42-45
- Бөлім: Profession: theory and practice
- URL: https://journal-vniispk.ru/0025-8342/article/view/267030
- DOI: https://doi.org/10.29296/25879979-2024-06-09
- ID: 267030
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
The main principle of epilepsy treatment is long-term regular intake of antiepileptic drugs (PEP) to reduce the frequency of seizures or their complete reduction in the absence of clinically significant side effects. Timely detection and correction of adverse reactions is an integral part of the treatment of epilepsy.
Негізгі сөздер
Толық мәтін
##article.viewOnOriginalSite##Авторлар туралы
Sergey Gulian
Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: serguliyan@gmail.com
Student
Ресей, VolgogradDiana Tsetsera
Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: diana.tsetsera@bk.ru
Student
Ресей, VolgogradVsevolod Skvortsov
Volgograd State Medical University of the Ministry of Health of the Russian Federation
Хат алмасуға жауапты Автор.
Email: vskvortsov1@ya.ru
ORCID iD: 0000-0002-2164-3537
Doctor of Medicine, Professor of the Department of Internal Medicine
Ресей, VolgogradIrina Rodionova
Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: vskvortsov1@ya.ru
Candidate of Medical Sciences, Associate Professor of the Department of Internal Medicine
Ресей, VolgogradӘдебиет тізімі
- Vera-González A. Pathophysiological Mechanisms Underlying the Etiologies of Seizures and Epilepsy. Exon Publications. 2022; 1–13.
- Chen J. et al. Pathogenesis of seizures and epilepsy after stroke. Acta Epileptologica. 2022; 4: 1–6.
- Scheffer I.E., Berkovic S., Capovilla G. et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58 (4): 512–521.
- Vezzani A., Fujinami R.S., White H.S. et al. Infections, inflammation and epilepsy. Acta Neuropathol. 2016; 131 (2): 211–234.
- Chen, J., Ye, H., Zhang, J. et al. Pathogenesis of seizures and epilepsy after stroke. Acta Epileptologica. 2022; 4 (2).
- Husari K.S., Dubey D. Autoimmune Epilepsy. Neurotherapeutics. 2019; 16 (3): 685–702.
- Toledano M., Pittock S.J. Autoimmune Epilepsy. Semin Neurol. 2015; 35 (3): 245–258.
- Beghi, Ettore. The epidemiology of epilepsy. Neuroepidemiology 2020; 54 (2): 185–191.
- Sarmast S.T., Abdullahi A.M., Jahan N. Current Classification of Seizures and Epilepsies: Scope, Limitations and Recommendations for Future Action. Cureus. 2020; 12 (9): e10549.
- Scheffer I.E., Berkovic S., Capovilla G. et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58 (4): 512–521. doi: 10.1111/epi.13709. Epub 2017 Mar 8.
- Hirtz D., Berg A., Bettis D. et al. Practice parameter: treatment of the child with a first unprovoked seizure report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003; 60: 166–175.
- Hauser W.A. Should people be treated after a first seizure? Arch Neurol. 1986; 43: 1287–1288.
- Pohlmann-Eden B., Beghi E., Camfield C. et al. The first seizure and its management in adults and children. BMJ. 2006; 332: 339.
- Parkerson K.A., Pathmanathan J.S., Milligan T.A. Optimizing antiepileptic treatment. JCOM. 2009; 16 (10).
- St L., Erik K., Rosenfeld W.E. et al. Antiepileptic drug monotherapy: the initial approach in epilepsy management. Curr Neuropharmacol. 2009; 7: 77–82.
- Wheless J.W. A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters. Expert Rev Neurother 2021; 21 (11): 1195–1205.
- Alvarez V., Lee J.W., Drislane F.W. et al. Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison. Epilepsia 2015; 56 (8): 1275–1285.
- Trinka E., Kälviäinen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure 2017; 44: 65–73.
- Kapur J., Elm J., Chamberlain J.M. et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. NETT and PECARN Investigators. N Engl J Med 2019; 381 (22): 2103–2113.
- Möddel G., Bunten S., Dobis C. et al. Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. J Neurol Neurosurg Psychiatry 2009; 80 (6): 689–692.
- Chamberlain J.M., Kapur J., Shinnar S. et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet 2020; 395 (10231): 1217–1224.
- Kim H.K., Lee H., Bae E-K. et al. Cardiac effects of rapid intravenous loading of lacosamide in patients with epilepsy. Epilepsy Res 2021; 176: 106710.
- Amengual-Gual M., Sanchez Fernandez I., Wainwright M.S. Novel drugs and early polypharmacotherapy in status epilepticus. Seizure 2019; 68 (3): 79–88.
- Fujikawa D.G. Starting ketamine for neuroprotection earlier than its current use as an anesthetic/antiepileptic drug late in refractory status epilepticus. Epilepsia 2019; 60 (5): 373–380.
Қосымша файлдар
